The effects of vasopressin injection on uterine artery blood flow during dilation and evacuation

Am J Obstet Gynecol. 2007 May;196(5):e38-9. doi: 10.1016/j.ajog.2006.10.389.

Abstract

Objective: This study was undertaken to determine whether vasopressin decreases uterine artery blood flow and blood loss in early second-trimester surgical abortions (dilation and evacuation).

Study design: Randomized, double blind, placebo-controlled trial of a saline paracervical block with or without vasopressin before dilation and evacuation. Uterine artery pulsatility index and blood loss were measured.

Results: Demographics were similar in both groups (mean gestational age 16.8 weeks, SD 1.7). Of 35 randomly assigned patients, Doppler waveforms were adequate in 28 patients (vasopressin, n = 13; placebo, n = 15). The mean difference in uterine artery pulsatility index before and after injection between groups was not significantly different (P = .14). Procedural blood loss was no different.

Conclusion: Paracervical vasopressin compared to placebo injection did not result in significant changes in uterine artery pulsatility index in early second-trimester dilation and evacuation procedures.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Induced*
  • Adult
  • Arteries / drug effects
  • Blood Loss, Surgical / prevention & control
  • Double-Blind Method
  • Female
  • Hemostasis, Surgical
  • Humans
  • Pregnancy
  • Regional Blood Flow / drug effects*
  • Uterus / blood supply*
  • Vasoconstrictor Agents / pharmacology*
  • Vasopressins / pharmacology*

Substances

  • Vasoconstrictor Agents
  • Vasopressins